In ASCO Daily News, Dana-Farber's Clark DuMontier, MD, MPH (@cdumonti) discusses how electronic tools and digital technology can overcome barriers to expanding geriatric/frailty assessment in routine care.
Read More ▶️
ms.spr.ly/6015Yd3AB

Great to see our timetoaccelerate.com/election manifesto gathering pace (and politicians' signatures!) Lets be a Europe that is Together Against Cancer - Make cancer an election issue - it affects one in two of us as some stage during our lifetime! Act NOW

Dear Colleagues,
The OncoAlert 🚨Network Presents OUR Picks of
TOP 🔟Abstracts to be Presented at #ASCO24

This List Curated by:
#OncoAlertAF Leads : Elisa Agostinetto 🇧🇪 Elisabetta Bonzano 🇮🇹 Gil Morgan, MD 🇺🇸
With our distinguished OncoAlert Faculty:
Erika Hamilton, MD 🇺🇸 Stephanie Graff, MD, FACP, FASCO

Ab#4533 ASCO #ASCO24 by Rana McKay👉 tinyurl.com/ysjhv6pu👉Matched tissue & ctDNA analysis in real-world database of #kidneycancer 👉⬆️mutation detection in ctDNA & increased concordance between ctDNA & tissue CGP in pts w/ metastatis👇DrBagrodia OncoAlert UroToday.com

Ab#5007 ASCO #ASCO24 by #SHalabi 👉tinyurl.com/4j224z4z👉A novel prognostic clinical-genetic model (including ctDNA) in mCRPC #prostatecancer 👉classifies pts into separate risk groups, may help pt selection for trials👇 Andrew Armstrong Michael Morris OncoAlert UroToday.com Uromigos

Thanks Neeraj Agarwal, MD, FASCO for always providing the preview of key GU abstracts ahead of ASCO meetings. Looking forward to an exciting #ASCO24

Toni Choueiri, MD ASCO OncoAlert Dana-Farber Lank Center for Genitourinary Oncology Impressive outcomes from the Camrelizumab + Apatinib phase 2 trial in advanced adrenocortical cancer, especially with an ORR of 52% and DCR of 95%. These results certainly warrant further investigation despite the small sample size. For more in-depth, AI-generated biomedical

Sarah Fitzgibbon Our condolences to Patricia's family and friends. We recently received a powerful letter from Patricia advocating for measures to support the early diagnosis of CRC in Ireland, including in people below the screening age. It is published in our current edition.

So sorry to hear this. Patricia was an incredible patient advocate - you can read her passion and commitment in the letter below, published in the current edition of Medical Independent. May she rest in peace.

It is with our deepest sorrow that we announce the passing of our beloved friend and co-founder, Patricia.
In < 2 years of our foundation, we lost 3 of our founding advocates. All diagnosed well below screening age.
Please help us to keep her legacy alive
change.org/p/lower-the-ag…

New research in nature by Jared Johnson, PhD, Cantley Lab Dana-Farber provides an atlas of the substrate specificities for the human tyrosine kinome, enabling researchers to find tyrosine kinases likely to phosphorylate their favorite proteins.

➡️ ms.spr.ly/6014YVJeu

#tbt to the most edifying radiology report I've ever read

Interesting new computational framework (EpiTrace) infers cell mitotic age from single cell ATAC-seq data to predict developmental and disease trajectories, nice complement to somatic variation and RNA velocity methods. github.com/MagpiePKU/EpiT… nature.com/articles/s4158…

Sincere thanks to HEA and North South Research Programme for their part sponsorship of our recent Joint EU-American Forum on Cancer through the AICRIstart, eHealth Hub for Cancer & CLuB Consortium funded programmes HEA #NSRPproject eHealth4Cancer CLuB Aedin Culhane (@[email protected])

Limerick Digital Cancer Research Centre would like to invite you to a mini-symposium on Spatial Biology taking place on campus on 24th April. Registration and more info on the talks is available on clicking on the QR code Colum Dunne Aedin Culhane (@[email protected])

Intriguing insights from Dr. Monica M. Bertagnolli on the microbiome and #ColorectalCancer . Research suggests a microbe normally found in the mouth could influence colorectal cancer progression—perhaps one day it could be used as a target for screening + treatment. go.nih.gov/KL1Oltd